Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial
=====================================================================================================================================================================================

* Jason A Chesney
* Igor Puzanov
* Frances A Collichio
* Parminder Singh
* Mohammed M Milhem
* John Glaspy
* Omid Hamid
* Merrick Ross
* Philip Friedlander
* Claus Garbe
* Theodore Logan
* Axel Hauschild
* Celeste Lebbé
* Harshada Joshi
* Wendy Snyder
* Janice M Mehnert